Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · May 06, 2024

Identification of Risk Factors for DPP-4 Inhibitor–Associated Bullous Pemphigoid in Patients With Diabetes

Acta Dermato-Venereologica

 

Additional Info

Acta Dermato-Venereologica
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
Acta Derm Venereol 2024 Apr 04;104(xx)adv26663, D Shalmon, E Bar-Ilan, A Peled, S Geller, J Bar, N Schwartz, E Sprecher, M Pavlovsky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading